⚠️⚕️ Health Canada Warns Consumers Not to Inhale Nitrous Oxide, Also Known as Laughing Gas, Recreationally
Thursday, 12 June 2025 08:00.AM
Summary
• Product: Various nitrous oxide products
• Issue: Health products – Product safety; Unauthorized product
• What to do: Do not inhale nitrous oxide products for recreational purposes. If you use prescription nitrous oxide recreationally and experience side effects, seek medical attention immediately.
Affected products
Various nitrous oxide products. Examples of seized products include:
• Bamboozle
• Need Whip
• Primewhip
• Primewhip XL
• Space Gas
Issue
Health Canada is warning consumers about the serious health risks, including death, of inhaling nitrous oxide products, also known as laughing gas and by various street names, such as "whippets," "hippy crack," "NOS" and "nang," for recreational purposes.
In Canada, nitrous oxide sold for inhalation is a drug and can only be administered by an authorized health care professional for legitimate and safe uses, such as in medical and dental procedures for sedation and pain relief. It is also in cream dispensers and other food tools where it is not meant to be inhaled.
When inhaled—or "huffed" —nitrous oxide can cause euphoria and relaxation. It can also cause serious adverse effects such as:
• loss of consciousness and in some cases, death
• birth defects
• anemia, vitamin B12 deficiency
• impaired bowel and bladder function
• confusion, agitation, delusions, hallucinations, paranoia and depression
• increased heart rate, palpitations, low blood pressure, heart attack and stroke
• lack of oxygen in the body (asphyxia), blood clots in the extremities and in the lungs, and air leaks into the space between the lung and chest wall (pneumothorax)
• tingling, numbness and weakness of the limbs and extremities (fingers and toes), uncoordinated walking and falls
• nerve damage, spinal cord degeneration, prolonged pain and, in severe cases, permanent paralysis
Repeated use increases the likelihood of severe outcomes and may result in lasting neurological damage, even after stopping use. Regular use can also lead to addiction and withdrawal symptoms.
Advertising and selling nitrous oxide products for inhalation to the public is strictly prohibited. However, Health Canada is aware that these products are being sold online and in retail stores. These products may be deceptively labelled:
• as "whip cream chargers,"
• in flavours, which are not permitted,
• in stores you would not expect to find whipped cream chargers; and
• in large containers you would not expect for dispensing whipped cream.
Health Canada has not reviewed these products, which are regulated as drugs, for safety, efficacy or quality. Also, they could be contaminated in ways that create additional health risks when inhaled.
Health Canada strongly advises that consumers not inhale any nitrous oxide products for recreational purposes.
Health Canada has seized several unauthorized nitrous oxide products and has worked with Canada Border Services Agency (CBSA) to stop unauthorized shipments from entering the country. The Department will continue to take action to stop the sale of unauthorized products and to work with CBSA to help prevent further importations.
What you should do
• Do not inhale nitrous oxide products for recreational purposes.
• Seek immediate medical attention from a health care professional (physician, nurse, pharmacist, Canadian Poison Centre) if you have used nitrous oxide recreationally or for medical purposes and have experienced any side effects.
• For Poison Centre access you can contact 1-844 POISON-X, in Quebec 1-800-463-5060, or contact your local poison centre directly. Health Canada has also published information about stopping substance use.
• Report any health product-related side effects or complaints to Health Canada.
SOURCE: Health Canada
-
Related materials:
- 25-Jan-2026 02:11 PM 🍁💵⚕️ Ontario Opens Homelessness and Addiction Recovery Treatment Hub in Dufferin County
- 03-Jan-2026 12:00 PM ⚕️💊Health Canada Approves TEVIMBRA® (tislelizumab for injection) in Combination with Gemcitabine and Cisplatin for the First-Line Treatment of Adult Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma
- 03-Jan-2026 08:41 AM ⚕️OTO Fertility Launches World's First AI-Powered Platform & Wearable for Predictive Reproductive Insight
- 03-Jan-2026 02:58 AM ⚠️⚕️Public Health Notice: Outbreak Of E. Coli Infections Linked to Pillsbury Brand Pizza Pops
- 19-Dec-2025 12:00 AM ⚕️Health Canada proposes to ban advertising of vaping products wherever they can be seen or heard by youth
- 09-Dec-2025 10:11 AM ⚕️💊 High-risk Early Breast Cancer Patients in Quebec Left Behind by Recent INESSS Recommendation
- 08-Dec-2025 10:27 AM ⚕️💊 With Child Deaths Projected to Rise for the First Time This Century, Gates Foundation Urges Global Leaders to Target Scarce Resources Where They Save the Most Lives
- 07-Dec-2025 04:06 PM ⚠️⚕️Various Pistachios and Pistachio-Containing Products Recalled Due to Salmonella
- 29-Nov-2025 12:00 PM ⚕️💵Canada's $1.5-billion Rare Disease Drug Strategy generating 'return on investment' for patients and society but more needs to be done
- 29-Nov-2025 08:00 AM ⚕️🦷Canadian Dental Care Plan Reaches New Milestone as Government of Canada Strengthens Access to Oral Health Care